NLM Logo

sacubitril and valsartan sodium hydrate drug combination MeSH Supplementary Concept Data 2022


MeSH Supplementary
sacubitril and valsartan sodium hydrate drug combination
Unique ID
C549068
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C549068
Entry Term(s)
3-(1-biphenyl-4-ylmethyl-3-ethoxycarbonyl-1-butylcarbamoyl)propionate-3'-methyl-2'-(pentanoyl(2'-(tetrazol-5-ylate)biphenyl-4'-ylmethyl)amino)butyrate
Entresto
LCZ 696
LCZ-696
LCZ696
sacubitril and valsartan drug combination
sacubitril and valsartan sodium anhydrous drug combination
sacubitril valsartan drug combination
sacubitril valsartan sodium anhydrous
sacubitril valsartan sodium hydrate
sacubitril-valsartan
sacubitril-valsartan sodium anhydrous drug combination
sacubitril-valsartan sodium hydrate drug combination
trisodium (3-(1-biphenyl-4-ylmethyl-3-ethoxycarbonyl-1-butylcarbamoyl)propionate-3'-methyl-2'-(pentanoyl(2'-(tetrazol-5-ylate)biphenyl-4'-ylmethyl)amino)butyrate) hemipentahydrate
Pharm Action
Angiotensin Receptor Antagonists
Registry Number
WB8FT61183
Related Numbers
51T0V5Z5AD
Heading Mapped to
*Valsartan
*Aminobutyrates
*Biphenyl Compounds
Drug Combinations
Frequency
929
Note
an angiotensin II receptor antagonist
Source
Lancet 2010 Apr 10;375(9722):1255-66
Indexing Information
Neprilysin
Date of Entry
2010/05/02
Revision Date
2021/05/14
sacubitril and valsartan sodium hydrate drug combination Preferred
sacubitril and valsartan drug combination Broader
sacubitril and valsartan sodium anhydrous drug combination Narrower
LCZ 696 Narrower
Entresto Narrower
page delivered in 0.006s